Neurobo Pharmaceuticals Inc.

This early-stage study tests a new drug called DA-1726 in 139 people with obesity who are otherwise healthy. The main goal is to check if the drug is safe and to see how the body handles it. Researchers will also look at how the drug affects body composition and weight.